BIOLITEC AG PRESS RELEASE
biolitec biomedical technology GmbH Otto-Schott-Straße 15
07745 Jena www.biolitec.de
HOLA™ laser therapy by biolitec® shows significant advantages compared to other gynecological therapies - International School of Laser Hysteroscopy founded in Barcelona HOLA™ laser therapy is the new alternative myoma treatment - used to gently remove myomas and polyps - International School of Hysteroscopy founded in Barcelona
Jena, May 5, 2015 - The HOLA™ laser therapy by biolitec is a gentle and effective outpatient laser treatment which can be performed under local anesthesia. Its laser light precisely removes the diseased tissue as it can be focused in a way that no surrounding tissue is damaged or open wounds are caused.
For the around 20 per cent of women at a childbearing age who suffer from myomas, numerous therapy options are available. Depending on size, position, and amount of the myomas, different therapy options may be applicable. However the biolitec laser therapy HOLA™ combines all the positive characteristics of a hysteroscopic treatment (a treatment through the vagina), and therefore differentiates itself in a positive way from other therapies in terms of application and result. The new HOLA laser therapy can reduce the risk of scar tissue and bleeding in the uterus. Especially when treating patients with the desire to have children therapies which preserve the uterus should be in the focus.
It depends on the physician's recommendation if an embolization, which is the destruction of myomas through the injection of tiny gelatinous or plastic particles into the vascular system, or morcellation, where the myoma is mechanically destroyed, may be among the right therapy options. However the FDA currently calls for caution when performing morcellation, since in some rare cases a scattering of unrecognized malignant tissue into the abdominal region may occur due to shredding myoma.
1/2
PRESS RELEASE
biolitec biomedical technology GmbH Otto-Schott-Straße 15
07745 Jena www.biolitec.de
During a hysteroscopic treatment a very thin tube with a small optic and a laser probe are led into the uterine cavity through the vagina, where the treatment is then very gently performed.
At the International School of Laser Hysteroscopy, gynecologists have the opportunity to receive profound specific training in the field of laser-based therapies in order to be able to perform outpatient treatments under local anesthesia.
About biolitec:
biolitec AG is one of the leading companies worldwide in the field of medical laser treatments and the only provider that possesses all relevant core competencies -
photosensitizers, laser devices and optical fibers - in the field of photodynamic therapy (PDT). Besides laser-based treatment of cancer with the drug Foscan®, biolitec AG primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) is the most often used laser system worldwide for the treatment of varicose veins. In combination with the Ceralas® HPD laser, the innovative contact fiber XCAVATOR® enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. The new LEONARDO® diode laser by biolitec® is the first universally applicable medical laser which features a combination of two wavelengths,
980nm and 1470nm, and is suitable for interdisciplinary use. Gentle laser treatments in the fields of proctology, ENT, gynecology, thoracic surgery as well as pneumology also belong to the business field of biolitec AG. Further information at www.biolitec.com.
Press contact:
Joern Gleisner
Telephone: +49 (0) 6172/27159-11
Telefax: +49 (0) 6172/27159-69
E-Mail: joern.gleisner@biolitec.com
2/2
|
distributed by
|
